Page last updated: 2024-09-02

deoxyglucose and Cytokine Release Syndrome

deoxyglucose has been researched along with Cytokine Release Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Hida, S; Kajita, M; Naito, Z; Onda, M; Taki, S; Tanaka, N; Tanimura, A; Uehara, I1
Adhikary, A; Dwarakanath, BS; Papineni, RVL; Verma, A; Woloschak, G1

Other Studies

2 other study(ies) available for deoxyglucose and Cytokine Release Syndrome

ArticleYear
2-Deoxy-d-glucose induces deglycosylation of proinflammatory cytokine receptors and strongly reduces immunological responses in mouse models of inflammation.
    Pharmacology research & perspectives, 2022, Volume: 10, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cytokine Receptor gp130; Cytokine Release Syndrome; Cytokines; Deoxyglucose; Glycosylation; Inflammation; Janus Kinases; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cytokine; Receptors, Interleukin-6

2022
A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
    International journal of radiation biology, 2020, Volume: 96, Issue:11

    Topics: Betacoronavirus; Combined Modality Therapy; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Deoxyglucose; Humans; Pandemics; Pneumonia, Viral; Radiotherapy Dosage; SARS-CoV-2

2020